TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
Dodhiawala PB, Khurana N, Zhang D, Cheng Y, Li L, Wei Q, Seehra K, Jiang H, Grierson PM, Wang-Gillam A, Lim KH.
Dodhiawala PB, et al. Among authors: khurana n.
J Clin Invest. 2020 Sep 1;130(9):4771-4790. doi: 10.1172/JCI137660.
J Clin Invest. 2020.
PMID: 32573499
Free PMC article.